Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

27 July 2015
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

ConforMIS, Inc. to Host Second Quarter 2015 Financial Results Conference Call and Webcast on August 11, 2015

Read more ››
By: Nasdaq / GlobenewsWire - 28 Jul 2015
Related companies:  ConforMIS, Inc.

Amooranin Preclinical Sample Batch Completed

LAS VEGAS, July 27, 2015 /PRNewswire/ -- EnzymeBioSystems (OTC BB: ENZB - News) announces that a preclinical methyl amooranin batch has been completed. Amooranin is the Company's lead pharmaceutical product. EnzymeBioSystems plans to seek approval for the use of methyl amooranin in the prevention... Read more ››

By: PR Newswire Association LLC. - 28 Jul 2015

PDA: Dental ER Visits Continue to Increase; How to Avoid Them

HARRISBURG, Pa., July 27, 2015 /PRNewswire-USNewswire/ -- Thinking your toothache isn't that big of a deal? Over the past several years, there has been a steady increase of people finding themselves in the emergency room for dental problems. While this is an issue that's often forgotten about,... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders

HERTFORDSHIRE, England and PITTSBURGH, July 27, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that it will hold its extraordinary general meeting of shareholders in connection with its proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE) at the Okura Hotel Amsterdam... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Mylan (UK)

Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million

CHESTERFIELD, United Kingdom, July 27, 2015 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty biopharmaceutical company, announced today that it has entered into a definitive agreement under which it will... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Blue Cross and Blue Shield of Illinois' Private Exchange Now Offers Employers Increased Plan Options, Member Support and Transparency Tools

CHICAGO, July 27, 2015 /PRNewswire-USNewswire/ -- Blue Cross and Blue Shield of Illinois (BCBSIL) today announced several enhancements to its Blue Directions self-service, private exchange solution for large employers, and available now for the upcoming 2016 benefit plan year. Based on a defined... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Elsevier and ADSA® Proudly Announce Winners of the Fifth Annual Journal of Dairy Science® Most-Cited Awards

PHILADELPHIA, July 27, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Elsevier Inc. | Elsevier Inc.

BPC Releases Bold Recommendations to Advance Medical Innovation, Help Cure Life-Threatening Diseases, and Improve U.S. Competitiveness in the Global Marketplace

WASHINGTON, July 27, 2015 /PRNewswire-USNewswire/ -- Today there are 10,000 known diseases in the United States, but only 500 have established treatments. Life-threatening diseases such as Alzheimer's, cancer, heart disease, and many others lack effective treatments or cures. The urgent need... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Aspyrian Therapeutics Inc. Closes $4.25M Series A Extension Financing to Support the Execution of Phase 1 Clinical Studies of the Precision Targeted Cancer Therapy, RM-1929, to Treat Late-Stage Recurrent Head and Neck Cancers

SAN DIEGO, July 27, 2015 /PRNewswire/ -- Aspyrian Therapeutics Inc., a clinical stage drug development company creating precision-targeted therapies to treat cancer based on its proprietary Photoimmunotherapy platform has secured $4.25 million as part of a Series A extension financing. This financing... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Capella Healthcare Announces Agreement With Medical Properties Trust, Inc.

CHICAGO and FRANKLIN, Tenn., July 27, 2015 /PRNewswire/ -- Capella Healthcare, Inc. ("Capella"), a privately-owned premier provider of health care services and one of the largest for-profit hospital companies in the U.S., today announced that its parent company and sole stockholder, Capella... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Nexus Properties | Capella Therapeutics

Amgen Announces Webcast of 2015 Second Quarter Financial Results

THOUSAND OAKS, Calif., July 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Thursday, July 30, 2015, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Amgen, Inc.

Egalet Announces Proposed Public Offering of Common Stock

WAYNE, Pa., July 27, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, announced today that it intends to offer and sell shares of its common stock... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Egalet Danmark

Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA

DUBLIN and WESTLAKE VILLAGE, Calif., July 27, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Kythera Biopharmaceuticals, Inc.

New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue

Read more ››
By: Nasdaq / GlobenewsWire - 27 Jul 2015
Related companies:  Sanofi S.A.

D-dimer Testing Market - Global Industry Analysis 2015

DUBLIN, July 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4rvprn/ddimer_testing) has announced the addition of the Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Denver Back Pain Specialists Physicians Begin Enrollment in Stem Cell Therapy Study in Subjects with Chronic Back Pain

DENVER, July 27, 2015 /PRNewswire/ -- Denver Back Pain Specialists today announced that it has enrolled its first patient in a nationwide FDA- cleared adult stem cell study (phase 3) testing an investigational treatment for chronic low back pain associated with degenerative disc disease. The... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Physician-Patient Alliance for Health & Safety Turns 4 Years Old

CHICAGO, July 27, 2015 /PRNewswire/ -- The Physician-Patient Alliance for Health & Safety (PPAHS) today celebrates its fourth anniversary.

Read more ››
By: PR Newswire Association LLC. - 27 Jul 2015

The "Bomb Boat" of Martha's Vineyard: Travelers' Warning from Physicians for Civil Defense

TUCSON, Ariz., July 27, 2015 /PRNewswire-USNewswire/ -- The "Bomb Boat" is ferry workers' nickname for the MV Sankaty, which carries fuel tanker trucks. It docks next to the passenger ferry Island Home, which can carry up to 1,000 passengers, according to Stephen Jones, Special Projects Director... Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015

Dynatronics Awarded CE Mark Approval for Its Solaris Products

SALT LAKE CITY, July 27, 2015 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced it has received CE Mark approval for its Solaris therapeutic modality products. This approval allows the company to sell these products in Europe and many other countries around the world.

Read more ››
By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Dynatronics Corporation

G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

DUBLIN, July 17, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/65t478/gprotein_coupled) has announced the addition of the Read more ››

By: PR Newswire Association LLC. - 27 Jul 2015
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next